OBJECTIVE: To evaluate changes in cardiovascular disease risk surrogate markers in a longitudinal cohort of HIV-infected adults over 6 years. DESIGN: Internal carotid artery (ICA) and common carotid artery (CCA) intima-media thickness (IMT), coronary artery calcium (CAC), vascular, and HIV risk factors were prospectively examined over 6 years in HIV-infected adults from 2002 to 2010. SETTING: Longitudinal cohort study with participants from urban center and surrounding communities. SUBJECTS/PARTICIPANTS: Three hundred forty-five HIV-infected participants were recruited from a longitudinal cohort study. Two hundred eleven participants completed the study and were included in this analysis. MAIN OUTCOME MEASURES: Total and yearly ICA and CCA IMT change; CAC score progression. RESULTS: Participants were 27% female and 49% nonwhite; mean age at start was 45 ± 7 years. The median change in ICA and CCA over 6 years was 0.15 mm (0.08, 0.28) and 0.12 mm (0.09, 0.15), respectively. Age, baseline triglycerides ≥150 mg/dL, and pack-years smoking were associated with ICA IMT change; age, cholesterol, nadir CD4 count, and protease inhibitor use were associated with CCA IMT change. Diabetes, HIV viral load, and highly active antiretroviral therapy duration were associated with CAC progression. CONCLUSIONS: Carotid IMT and CAC progressed in this HIV-infected cohort. Some HIV-specific characteristics were associated with surrogate marker changes, but the majority of risk factors continue to be traditional. Aggressive identification and management of modifiable risk factors may reduce progression of cardiovascular disease risk in this population.
OBJECTIVE: To evaluate changes in cardiovascular disease risk surrogate markers in a longitudinal cohort of HIV-infected adults over 6 years. DESIGN: Internal carotid artery (ICA) and common carotid artery (CCA) intima-media thickness (IMT), coronary artery calcium (CAC), vascular, and HIV risk factors were prospectively examined over 6 years in HIV-infected adults from 2002 to 2010. SETTING: Longitudinal cohort study with participants from urban center and surrounding communities. SUBJECTS/PARTICIPANTS: Three hundred forty-five HIV-infectedparticipants were recruited from a longitudinal cohort study. Two hundred eleven participants completed the study and were included in this analysis. MAIN OUTCOME MEASURES: Total and yearly ICA and CCA IMT change; CAC score progression. RESULTS:Participants were 27% female and 49% nonwhite; mean age at start was 45 ± 7 years. The median change in ICA and CCA over 6 years was 0.15 mm (0.08, 0.28) and 0.12 mm (0.09, 0.15), respectively. Age, baseline triglycerides ≥150 mg/dL, and pack-years smoking were associated with ICA IMT change; age, cholesterol, nadir CD4 count, and protease inhibitor use were associated with CCA IMT change. Diabetes, HIV viral load, and highly active antiretroviral therapy duration were associated with CAC progression. CONCLUSIONS: Carotid IMT and CAC progressed in this HIV-infected cohort. Some HIV-specific characteristics were associated with surrogate marker changes, but the majority of risk factors continue to be traditional. Aggressive identification and management of modifiable risk factors may reduce progression of cardiovascular disease risk in this population.
Authors: J J Carr; J A Danitschek; D C Goff; J R Crouse; R D'Agostino; M Y Chen; G L Burke Journal: Int J Cardiovasc Imaging Date: 2001-06 Impact factor: 2.357
Authors: Heather M Johnson; Pamela S Douglas; Sathanur R Srinivasan; M Gene Bond; Rong Tang; Shengxu Li; Wei Chen; Gerald S Berenson; James H Stein Journal: Stroke Date: 2007-02-01 Impact factor: 7.914
Authors: G Howard; L E Wagenknecht; G L Burke; A Diez-Roux; G W Evans; P McGovern; F J Nieto; G S Tell Journal: JAMA Date: 1998-01-14 Impact factor: 56.272
Authors: Samuel A Bozzette; Christopher F Ake; Henry K Tam; Sophia W Chang; Thomas A Louis Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: Joshua A Walker; Andrew D Miller; Tricia H Burdo; Michael S McGrath; Kenneth C Williams Journal: J Acquir Immune Defic Syndr Date: 2017-04-15 Impact factor: 3.731
Authors: David B Hanna; Wendy S Post; Jennifer A Deal; Howard N Hodis; Lisa P Jacobson; Wendy J Mack; Kathryn Anastos; Stephen J Gange; Alan L Landay; Jason M Lazar; Frank J Palella; Phyllis C Tien; Mallory D Witt; Xiaonan Xue; Mary A Young; Robert C Kaplan; Lawrence A Kingsley Journal: Clin Infect Dis Date: 2015-04-22 Impact factor: 9.079
Authors: Martin Krsak; David M Kent; Norma Terrin; Christina Holcroft; Sally C Skinner; Christine Wanke Journal: AIDS Patient Care STDS Date: 2015-04-09 Impact factor: 5.078
Authors: T S Metkus; T Brown; M Budoff; L Kingsley; F J Palella; M D Witt; X Li; R T George; L P Jacobson; W S Post Journal: HIV Med Date: 2015-05-13 Impact factor: 3.180
Authors: Duy M Dinh; Gretchen E Volpe; Chad Duffalo; Seema Bhalchandra; Albert K Tai; Anne V Kane; Christine A Wanke; Honorine D Ward Journal: J Infect Dis Date: 2014-07-23 Impact factor: 5.226
Authors: David B Hanna; Mengye Guo; Petra Bůžková; Tracie L Miller; Wendy S Post; James H Stein; Judith S Currier; Richard A Kronmal; Matthew S Freiberg; Siiri N Bennett; Cecilia M Shikuma; Kathryn Anastos; Yanjie Li; Russell P Tracy; Howard N Hodis; Joseph A Delaney; Robert C Kaplan Journal: Clin Infect Dis Date: 2016-04-26 Impact factor: 9.079
Authors: Mark J Siedner; June-Ho Kim; Ruth Sentongo Nakku; Prossy Bibangambah; Linda Hemphill; Virginia A Triant; Jessica E Haberer; Jeffrey N Martin; A Rain Mocello; Yap Boum; Douglas S Kwon; Russell P Tracy; Tricia Burdo; Yong Huang; Huyen Cao; Samson Okello; David R Bangsberg; Peter W Hunt Journal: J Infect Dis Date: 2015-09-07 Impact factor: 5.226